Probi

Probi FCF Conversion

Delisted

The FCF Conversion Rate (FCF/EBITDA) of Probi (PROB.ST) as of Sep 25, 2026 is 186.49 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 225.21 % — a change of -17.20% (lower).

FCF Conversion

186.49 %

YoY

-17.20%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Probi is 2026 186.49 % . FCF Conversion Rate (FCF/EBITDA) of Probi was 2025 225.21 % . It decreases by -17.20% lower compared to the previous year.

The Probi FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2016
62.65 SEK
Jan 1, 2017
172.79 SEK
Jan 1, 2018
149.28 SEK
Jan 1, 2019
161.21 SEK
Jan 1, 2020
107.88 SEK
Jan 1, 2021
134.26 SEK
Jan 1, 2022
225.21 SEK
Jan 1, 2023
186.49 SEK
The Probi FCF Conversion history
YEARFCF ConversionYoY
186.49 %-17.20%
225.21 %+67.74%
134.26 %+24.46%
107.88 %-33.08%
161.21 %+7.99%
149.28 %-13.60%
172.79 %+175.78%
62.65 %-27.86%
86.85 %-19.85%
108.37 %—
Access this data via the Eulerpool API

Probi Stock analysis

What does Probi do? Probi AB is a Swedish company that specializes in the development and production of probiotic products. Founded in 1991 as a spin-off from Lund Institute of Technology, Probi is now represented in Sweden, the USA, and India with approximately 200 employees. The business model of Probi is based on research and development of probiotic bacterial cultures, as well as marketing probiotic products developed in collaboration with customers and partners. The company's business divisions are divided into probiotic products and research and development. Probiotic products: Probi produces a wide range of probiotic products, including dietary supplements, functional foods, animal feed, and medical devices. These products contain live microorganisms intended to support gut health and strengthen the immune system. Probi works closely with customers and partners to develop tailored solutions. Research and development: An important part of Probi's business is the research and development of probiotic bacterial cultures. Research findings serve as the basis for new products and applications. Probi has its own research department equipped with state-of-the-art laboratory technologies. In addition, Probi collaborates closely with partners from the academic and industrial sectors to explore new technologies and applications. Probi's history originally began in the 1980s at Lund Institute of Technology in Sweden, where the foundation for the development of probiotics was laid. In 1991, Probi was established as a spin-off from the institute, initially focusing on research and development of probiotic bacterial cultures. Over the following years, the company expanded internationally and developed more and more products and applications. Today, Probi is a leading global provider of probiotic products and solutions. Probi's products include probiotic capsules and tablets, probiotic yogurts, beverages, and dietary supplements. These products are intended to stabilize gut flora and strengthen the immune system. Additionally, Probi offers animal feed with probiotic bacterial cultures to promote the health of livestock. An important aspect of Probi is its collaboration with partners and customers. Through these partnerships, innovative products and solutions are developed to meet the needs of customers. Probi works closely with the food industry, healthcare sector, and animal feed industry. The future of Probi looks promising. The company aims to continue developing innovative products and solutions to promote the health of humans and animals. A strong growth strategy will also be pursued to further expand international presence. Probi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Probi stock

FCF Conversion Rate (FCF/EBITDA) of Probi is 186.49 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Probi changed from 225.21 % to 186.49 %, representing a -17.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Probi since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Probi with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Probi

All Key Metrics — Probi